UNSPSC 51286802: Iclaprim mesilate or mesylate

This classification denotes an antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7U972CJ5AT. European Medicines Agency schedules Iclaprim mesylate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB28993. Iclaprim mesilate generally arises in the molecular formula C19H22N4O3.CH4O3S. The term 'iclaprim mesilate' is a United States Adopted Name designation.

UNSPSC 51286802 Iclaprim mesilate or mesylate is a Commodity code for a specific pharmaceutical active ingredient, but state and local procurement activity under this code shows minimal relevant recent activity. The two opportunities tagged to this code in the recent-opportunities block both involve unrelated pharmaceutical products: the Illinois Department of Public Health's August 2026 piggyback award to Chartwell Rx LLC for Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets, and Seminole County, Florida's June 2026 IFB for Naloxone and Safe Drug Deactivation Systems. Neither solicitation concerns iclaprim mesilate specifically, suggesting the code assignment reflects a cataloging mismatch rather than active procurement demand for this particular antimicrobial agent.

The source provides no evidence of genuine market activity for iclaprim mesilate under this code at the state and local level. The two tagged opportunities represent distinct pharmaceutical categories — antibiotics and opioid-overdose reversal agents — that occupy different supply chains and clinical use cases. Without documented solicitations, awards, or state and local health department purchasing patterns specifically targeting iclaprim mesilate, this code does not currently represent a viable pursuit opportunity for vendors in the state and local pharmaceutical space.